RCT | Overall survival with Brentuximab Vedotin in stage III or IV Hodgkin’s lymphoma.

Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma – New England Journal of Medicine (link to abstract – $ for full-text)

News Release: Brentuximab vedotin may improve overall survival in patients with Hodgkin Lymphoma – Mayo Clinic